VENTRIPOINT DIAGNOSTICS LTD

Profile

Company Names

VENTRIPOINT DIAGNOSTICS LTD

Addresses

SUITE 1000 - LIVINGSTON PLACE WEST, 250 2ND STREET, SW, CALGARY, A0 T2P 0C1

100 WEST HARRISON ST., NORTH TOWER 110, SEATTLE, WA 98119

100 WEST HARRISON STREET, NORTH TOWER SUITE 110, SEATTLE, WA 98119

SUITE 1600, DOME TOWER, 333 - 7TH AVENUE S.W., CALGARY, A0 T2P 2Z1

100 WEST HARRISON, SUITE #410, SEATTLE, WA 98119

100 WEST HARRISON, SUITE 410, SEATTLE, WA 98119

100 WEST HARRISON, SUITE #410, SEATTLE, WA 98119

Phone Numbers

206-283-0221
(206) 283-0221

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$3,961,400.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2014-12-31 
$30,104.00 
$30,104.00 
$0.00 
Equity, Debt 
8
2013-07-26 
$20,000.00 
$20,000.00 
$0.00 
Equity, Debt 
7
2013-05-17 
$748,000.00 
$748,000.00 
$0.00 
Debt 
6
2013-03-28 
$50,217.00 
$482,228.00 
$432,011.00 
Equity 
5
2012-05-01 
$264,605.00 
$471,328.00 
$206,723.00 
Equity 
4
2011-06-09 
$1,159,798.00 
$3,000,000.00 
$1,840,202.00 
Equity 
3
2010-12-23 
$1,452,748.00 
$1,452,748.00 
$0.00 
Equity 
2
2010-10-04 
$97,714.00 
$97,714.00 
$0.00 
Equity 
1
2010-03-01 
$138,214.00 
$138,214.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GEORGE 
 
ADAMS 
EXECUTIVE OFFICER, DIRECTOR
JOSEPH 
 
ASHLEY 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
 
ASHLEY 
EXECUTIVE OFFICER
DON 
 
BLACK 
DIRECTOR
DON 
C. 
BLACK 
DIRECTOR
ELLEN 
 
BRIANT 
EXECUTIVE OFFICER
DANNY 
 
DALLA-LONGA 
DIRECTOR
EDWARD 
 
GARTH 
EXECUTIVE OFFICER
JERRY 
 
GATEWOOD 
EXECUTIVE OFFICER
JOHN 
 
GEBHART 
EXECUTIVE OFFICER
BRADLEY 
 
HARLOW 
DIRECTOR
BRADLEY 
RAINES 
HARLOW 
DIRECTOR
AMOL 
 
KARNICK 
EXECUTIVE OFFICER
TREUMAN 
 
KATZ 
DIRECTOR
TREUMAN 
KATZ 
DIRECTOR
TREUMAN 
P. 
KATZ 
DIRECTOR
DR. ALAN 
 
RABINOWITZ 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-12-31 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity, Debt 
2013-07-26 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2013-05-17 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-03-28 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-05-01 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-06-09 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-12-23 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-10-04 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-03-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#